JBC:肿瘤分化因子(TDF)受体在乳腺癌中发挥关键作用

2012-01-22 MedSci MedSci原创

近日,波茨坦克拉克森大学(Clarkson University in Potsdam)的研究人员鉴定出来一个可能在调节乳腺癌进展过程中起关键作用的蛋白——Tumor Differentiating Factor (TDF),即肿瘤分化因子(TDF)结合蛋白,相关研究论文"Identification of Potential Tumor Differentiation Factor (TDF)

近日,波茨坦克拉克森大学(Clarkson University in Potsdam)的研究人员鉴定出来一个可能在调节乳腺癌进展过程中起关键作用的蛋白——Tumor Differentiating Factor (TDF),即肿瘤分化因子(TDF)结合蛋白,相关研究论文"Identification of Potential Tumor Differentiation Factor (TDF) Receptor from Steroid-responsive and Steroid-resistant Breast Cancer Cells"发表在新一期J Biol Chem杂志上。

尽管癌症发生率及死亡率在过去三十年间呈现下降趋势,乳腺癌依然是导致死亡的主要杀手:在2007年,根据美国疾控中心数据,乳腺癌造成美国约40,000人死亡,同时有另外200,000女性被诊断出患有乳腺癌。

早前研究证明TDF是一个可以降低乳腺癌细胞进展的垂体激素,乳腺癌细胞用TDF处理会丢失它们的癌症特征并且开始向正常乳腺细胞一样发挥作用,提示TDF具有抑制肿瘤的能力。然而,TDF如何发挥作用还不清楚,该项研究的主要领导人——Costel DarieDarie教授领导的研究组启动了一项针对在癌细胞中可能结合TDF并传递抗肿瘤信号的细胞受体的研究,试图揭示TDF的抗肿瘤作用机制。

Darie教授研究组发现了一个受体,标记为TDF-R,在乳腺中是唯一的,不在其它癌细胞中表达,暗示这样一个特异的表达与以前报道的TDF功能有关联性。

关于下一步的研究,Darie断言“发现针对TDF激素的受体将使我们完全有能力合理的设计具有阻断癌症进展的药物,并且我们也能够用把TDF作为乳腺癌起始及治疗进展的诊断标志物。”

Identification of Potential Tumor Differentiation Factor (TDF) Receptor from Steroid-responsive and Steroid-resistant Breast Cancer Cells.

Sokolowska I, Woods AG, Gawinowicz MA, Roy U, Darie CC.

Tumor differentiation factor (TDF) is a recently discovered protein, produced by the pituitary gland and secreted into the bloodstream. TDF and TDF-P1, a 20-amino acid peptide selected from the open reading frame of TDF, induce differentiation in human breast and prostate cancer cells but not in other cells. TDF protein has no identified site of action or receptor, and its mechanism of action is unknown. Here, we used TDF-P1 to purify and identify potential TDF receptor (TDF-R) candidates from MCF7 steroid-responsive breast cancer cells and non-breast HeLa cancerous cells using affinity purification chromatography (AP), and mass spectrometry (MS). We identified four candidate proteins from the 70-kDa heat shock protein (HSP70) family in MCF7 cells. Experiments in non-breast HeLa cancerous cells did not identify any TDF-R candidates. AP and MS experiments were validated by AP and Western blotting (WB). We additionally looked for TDF-R in steroid-resistant BT-549 cells and human dermal fibroblasts (HDF-a) using AP and WB. TDF-P1 interacts with potential TDF-R candidates from MCF7 and BT-549 breast cells but not from HeLa or HDF-a cells. Immunofluorescence (IF) experiments identified GRP78, a TDF-R candidate, at the cell surface of MCF7, BT-549 breast cells, and HeLa cells but not HDF-a cells. IF of other HSP70 proteins demonstrated labeling on all four cell types. These results point toward GRP78 and HSP70 proteins as strong TDF-R candidates and suggest that TDF interacts with its receptor, exclusively on breast cells, through a steroid-independent pathway.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036335, encodeId=d51420363357a, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jan 24 14:34:00 CST 2012, time=2012-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737947, encodeId=23531e37947b4, content=<a href='/topic/show?id=7cba1e231a3' target=_blank style='color:#2F92EE;'>#TDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17231, encryptionId=7cba1e231a3, topicName=TDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bc34327068, createdName=1249862am83(暂无昵称), createdTime=Wed Jun 20 18:34:00 CST 2012, time=2012-06-20, status=1, ipAttribution=)]
    2012-01-24 lily1616
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036335, encodeId=d51420363357a, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jan 24 14:34:00 CST 2012, time=2012-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737947, encodeId=23531e37947b4, content=<a href='/topic/show?id=7cba1e231a3' target=_blank style='color:#2F92EE;'>#TDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17231, encryptionId=7cba1e231a3, topicName=TDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bc34327068, createdName=1249862am83(暂无昵称), createdTime=Wed Jun 20 18:34:00 CST 2012, time=2012-06-20, status=1, ipAttribution=)]